1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. NEKs
  4. NEK4 Isoform

NEK4

NEK4 (NIMA-related kinase 4) is a serine/threonine protein kinase within the NEK family that contributes to the maintenance of cellular homeostasis through functions linked to cell-cycle regulation, primary cilia biology, and the DNA damage response (DDR)[1][2]. Mechanistically, NEK4 has been associated with cellular responses to double-stranded DNA damage and participates in pathways that preserve genomic stability, placing this kinase at the interface between cell-cycle control and DNA repair processes[1][3]. Evidence further indicates that NEK4 contributes to non-homologous end joining (NHEJ) through recruitment of DNA-dependent protein kinase (DNA-PK) to DNA-damage foci, supporting efficient repair of DNA double-strand breaks[1]. Beyond genome maintenance, NEK4 is linked to cilium integrity, microtubule stabilization, and primary cilia function, highlighting a functional connection between ciliogenesis and stress-response pathways[2][4]. In disease-related contexts, altered NEK4 activity has been associated with ciliopathy-relevant phenotypes, while dysregulated expression has been reported in several tumor types, supporting continued investigation of NEK4 in cancer and genomic-instability models[3][5]. Compared with related NEK family members, NEK4 remains relatively understudied, yet available evidence identifies two major isoforms, NEK4.1 and NEK4.2, which display distinct interaction profiles and differential effects on RNA-splicing regulation, indicating isoform-specific biological functions[4][5]. For experimental applications, NEK4 is frequently investigated in DDR, ciliogenesis, microtubule-dynamics, and senescence models, whereas selective NEK4-targeted pharmacological modulators remain limited in the current literature[1][3].

NEK4 Related Products (1):

Cat. No. Product Name Effect Purity
  • HY-183068
    AP4-43
    Inhibitor
    AP4-43 is an orally active CLK1, CLK4, PI3K, DDR1, EGFR and NEK4 inhibitor. AP4-43 reduces growth of mammalian colorectal cancer organoids. AP4-43 improves survival in a transgenic Drosophila model of KRAS-mutant colorectal cancer. AP4-43 can be used for the research of KRAS-mutant colorectal cancer.